Biofrontera (BFRI) EBIAT: 2020-2025
Historic EBIAT for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -$6.6 million.
- Biofrontera's EBIAT fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
- Latest data reveals that Biofrontera reported EBIAT of -$6.6 million as of Q3 2025, which was down 24.89% from -$5.3 million recorded in Q2 2025.
- In the past 5 years, Biofrontera's EBIAT ranged from a high of $5.6 million in Q1 2022 and a low of -$16.0 million during Q3 2021.
- For the 3-year period, Biofrontera's EBIAT averaged around -$4.9 million, with its median value being -$5.7 million (2024).
- Per our database at Business Quant, Biofrontera's EBIAT spiked by 257.36% in 2022 and then tumbled by 1,971.60% in 2025.
- Quarterly analysis of 5 years shows Biofrontera's EBIAT stood at -$14.5 million in 2021, then spiked by 80.80% to -$2.8 million in 2022, then surged by 226.61% to $3.5 million in 2023, then slumped by 139.59% to -$1.4 million in 2024, then fell by 17.29% to -$6.6 million in 2025.
- Its EBIAT was -$6.6 million in Q3 2025, compared to -$5.3 million in Q2 2025 and -$4.2 million in Q1 2025.